Although obesity and metabolic dysfunction are common in schizophrenia, the reasons that both asprosin, an orexigenic peptide, and PYY, an anorexigenic peptide, are low should be addressed as a separate research topic. The gene discussed is PYY; the disease is obesity disorder.